These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome. Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623 [TBL] [Abstract][Full Text] [Related]
23. Effect of gravidity on maternal serum markers for Down's syndrome. Barkai G; Goldman B; Ries L; Chaki R; Cuckle H Prenat Diagn; 1996 Apr; 16(4):319-22. PubMed ID: 8734805 [TBL] [Abstract][Full Text] [Related]
24. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Yaron Y; Cherry M; Kramer RL; O'Brien JE; Hallak M; Johnson MP; Evans MI Am J Obstet Gynecol; 1999 Oct; 181(4):968-74. PubMed ID: 10521763 [TBL] [Abstract][Full Text] [Related]
25. Maternal serum screening for birth defects: results of a Connecticut regional program. Benn PA; Horne D; Craffey A; Collins R; Ramsdell L; Greenstein R Conn Med; 1996 Jun; 60(6):323-7. PubMed ID: 8706425 [TBL] [Abstract][Full Text] [Related]
26. Human chorionic gonadotropin and unconjugated oestriol measurements in insulin-dependent diabetic pregnant women being screened for fetal Down syndrome. Palomaki GE; Knight GJ; Haddow JE Prenat Diagn; 1994 Jan; 14(1):65-8. PubMed ID: 7514290 [TBL] [Abstract][Full Text] [Related]
27. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns. Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738 [TBL] [Abstract][Full Text] [Related]
28. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869 [TBL] [Abstract][Full Text] [Related]
29. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome. Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657 [TBL] [Abstract][Full Text] [Related]
30. Screening of maternal serum for fetal Down's syndrome in the first trimester. Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983 [TBL] [Abstract][Full Text] [Related]
31. Risk of abnormal triple screen for Down syndrome is significantly higher in patients with female fetuses. Spong CY; Ghidini A; Stanley-Christian H; Meck JM; Seydel FD; Pezzullo JC Prenat Diagn; 1999 Apr; 19(4):337-9. PubMed ID: 10327139 [TBL] [Abstract][Full Text] [Related]
32. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21. Souter VL; Nyberg DA; El-Bastawissi A; Zebelman A; Luthhardt F; Luthy DA Prenat Diagn; 2002 Mar; 22(3):175-82. PubMed ID: 11920888 [TBL] [Abstract][Full Text] [Related]
33. Maternal serum alpha-fetoprotein levels and fetal outcome in early second-trimester oligohydramnios. Los FJ; Hagenaars AM; Marrink J; Cohen-Overbeek TE; Gaillard JL; Brandenburg H Prenat Diagn; 1992 Apr; 12(4):285-92. PubMed ID: 1377389 [TBL] [Abstract][Full Text] [Related]
34. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy. Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131 [TBL] [Abstract][Full Text] [Related]
35. Maternal serum inhibin levels in second-trimester Down's syndrome pregnancies. Cuckle HS; Holding S; Jones R Prenat Diagn; 1994 May; 14(5):387-90. PubMed ID: 7521963 [TBL] [Abstract][Full Text] [Related]
37. [Serum screening of pregnant women reveals Down syndrome. Analysis of biochemical markers for earlier detection]. Christiansen M; Larsen SO; Nørgaard-Pedersen B Lakartidningen; 1997 Dec; 94(51-52):4898-902. PubMed ID: 9454010 [TBL] [Abstract][Full Text] [Related]
38. Medians for second-trimester maternal serum markers: geographical differences and variation caused by median multiples-of-median equations. Vranken G; Reynolds T; Van Nueten J J Clin Pathol; 2006 Jun; 59(6):639-44. PubMed ID: 16731605 [TBL] [Abstract][Full Text] [Related]
39. Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin. Palomaki GE; Knight GJ; Haddow JE; Canick JA; Saller DN; Panizza DS Prenat Diagn; 1992 Nov; 12(11):925-30. PubMed ID: 1283634 [TBL] [Abstract][Full Text] [Related]